Table of Content

Table of Contents
1 RESEARCH SCOPE
1.1 Research Product Definition
1.2 Research Segmentation
1.2.1 Product Type
1.2.2 Main product Type of Major Players
1.3 Demand Overview
1.4 Research Methodology
2 GLOBAL VETERINARY VACCINE INDUSTRY
2.1 Summary about Veterinary Vaccine Industry
2.2 Veterinary Vaccine Market Trends
2.2.1 Veterinary Vaccine Production & Consumption Trends
2.2.2 Veterinary Vaccine Demand Structure Trends
2.3 Veterinary Vaccine Cost & Price
3 MARKET DYNAMICS
3.1 Manufacturing & Purchasing Behavior in 2020
3.2 Market Development under the Impact of COVID-19
3.2.1 Drivers
3.2.2 Restraints
3.2.3 Opportunity
3.2.4 Risk
4 GLOBAL MARKET SEGMENTATION
4.1 Region Segmentation (2017 to 2021f)
4.1.1 North America (U.S., Canada and Mexico)
4.1.2 Europe (Germany, UK, France, Italy, Rest of Europe)
4.1.3 Asia-Pacific (China, India, Japan, South Korea, Southeast Asia, Australia, Rest of Asia Pacific)
4.1.4 South America (Brazil,, Argentina, Rest of Latin America)
4.1.5 Middle East and Africa (GCC, North Africa, South Africa, Rest of Middle East and Africa)
4.2 Product Type Segmentation (2017 to 2021f)
4.2.1 Live Attenuated Vaccines
4.2.2 Inactivated Vaccines
4.2.3 DNA Vaccines
4.2.4 Others
4.3 Consumption Segmentation (2017 to 2021f)
4.3.1 Livestock
4.3.2 Swine
4.3.3 Chicken
4.3.4 Dog
4.3.5 Cat
4.3.6 Others
5 NORTH AMERICA MARKET SEGMENT
5.1 Region Segmentation (2017 to 2021f)
5.1.1 U.S.
5.1.2 Canada
5.1.3 Mexico
5.2 Product Type Segmentation (2017 to 2021f)
5.2.1 Live Attenuated Vaccines
5.2.2 Inactivated Vaccines
5.2.3 DNA Vaccines
5.2.4 Others
5.3 Consumption Segmentation (2017 to 2021f)
5.3.1 Livestock
5.3.2 Swine
5.3.3 Chicken
5.3.4 Dog
5.3.5 Cat
5.3.6 Others
5.4 Impact of COVID-19 in North America
6 EUROPE MARKET SEGMENTATION
6.1 Region Segmentation (2017 to 2021f)
6.1.1 Germany
6.1.2 UK
6.1.3 France
6.1.4 Italy
6.1.5 Rest of Europe
6.2 Product Type Segmentation (2017 to 2021f)
6.2.1 Live Attenuated Vaccines
6.2.2 Inactivated Vaccines
6.2.3 DNA Vaccines
6.2.4 Others
6.3 Consumption Segmentation (2017 to 2021f)
6.3.1 Livestock
6.3.2 Swine
6.3.3 Chicken
6.3.4 Dog
6.3.5 Cat
6.3.6 Others
6.4 Impact of COVID-19 in Europe
7 ASIA-PACIFIC MARKET SEGMENTATION
7.1 Region Segmentation (2017 to 2021f)
7.1.1 China
7.1.2 India
7.1.3 Japan
7.1.4 South Korea
7.1.5 Southeast Asia
7.1.6 Australia
7.1.7 Rest of Asia Pacific
7.2 Product Type Segmentation (2017 to 2021f)
7.2.1 Live Attenuated Vaccines
7.2.2 Inactivated Vaccines
7.2.3 DNA Vaccines
7.2.4 Others
7.3 Consumption Segmentation (2017 to 2021f)
7.3.1 Livestock
7.3.2 Swine
7.3.3 Chicken
7.3.4 Dog
7.3.5 Cat
7.3.6 Others
7.4 Impact of COVID-19 in Europe
8 SOUTH AMERICA MARKET SEGMENTATION
8.1 Region Segmentation (2017 to 2021f)
8.1.1 Brazil
8.1.2 Argentina
8.1.3 Rest of Latin America
8.2 Product Type Segmentation (2017 to 2021f)
8.2.1 Live Attenuated Vaccines
8.2.2 Inactivated Vaccines
8.2.3 DNA Vaccines
8.2.4 Others
8.3 Consumption Segmentation (2017 to 2021f)
8.3.1 Livestock
8.3.2 Swine
8.3.3 Chicken
8.3.4 Dog
8.3.5 Cat
8.3.6 Others
8.4 Impact of COVID-19 in Europe
9 MIDDLE EAST AND AFRICA MARKET SEGMENTATION
9.1 Region Segmentation (2017 to 2021f)
9.1.1 GCC
9.1.2 North Africa
9.1.3 South Africa
9.1.4 Rest of Middle East and Africa
9.2 Product Type Segmentation (2017 to 2021f)
9.2.1 Live Attenuated Vaccines
9.2.2 Inactivated Vaccines
9.2.3 DNA Vaccines
9.2.4 Others
9.3 Consumption Segmentation (2017 to 2021f)
9.3.1 Livestock
9.3.2 Swine
9.3.3 Chicken
9.3.4 Dog
9.3.5 Cat
9.3.6 Others
9.4 Impact of COVID-19 in Europe
10 COMPETITION OF MAJOR PLAYERS
10.1 Brief Introduction of Major Players
10.1.1 Merial
10.1.2 Merck
10.1.3 Boehringer Ingelheim
10.1.4 Zoetis
10.1.5 Virbac
10.1.6 Ceva
10.1.7 Elanco/Eli Lilly
10.1.8 Sindh Poultry Vaccine Centre
10.1.9 Bio-Labs
10.1.10 Vaksindo
10.2 Veterinary Vaccine Sales Date of Major Players (2017-2020e)
10.2.1 Merial
10.2.2 Merck
10.2.3 Boehringer Ingelheim
10.2.4 Zoetis
10.2.5 Virbac
10.2.6 Ceva
10.2.7 Elanco/Eli Lilly
10.2.8 Sindh Poultry Vaccine Centre
10.2.9 Bio-Labs
10.2.10 Vaksindo
10.3 Market Distribution of Major Players
10.4 Global Competition Segmentation
11 MARKET FORECAST
11.1 Forecast by Region
11.2 Forecast by Demand
11.3 Environment Forecast
11.3.1 Impact of COVID-19
11.3.2 Geopolitics Overview
11.3.3 Economic Overview of Major Countries
12 REPORT SUMMARY STATEMENT

List of Figure

List of Table
1.Table Veterinary Vaccine Product Type Overview
2.Table Veterinary Vaccine Product Type Market Share List
3.Table Veterinary Vaccine Product Type of Major Players
4.Table Brief Introduction of Merial
5.Table Brief Introduction of Merck
6.Table Brief Introduction of Boehringer Ingelheim
7.Table Brief Introduction of Zoetis
8.Table Brief Introduction of Virbac
9.Table Brief Introduction of Ceva
10.Table Brief Introduction of Elanco/Eli Lilly
11.Table Brief Introduction of Sindh Poultry Vaccine Centre
12.Table Brief Introduction of Bio-Labs
13.Table Brief Introduction of Vaksindo
14.Table Products & Services of Merial
15.Table Products & Services of Merck
16.Table Products & Services of Boehringer Ingelheim
17.Table Products & Services of Zoetis
18.Table Products & Services of Virbac
19.Table Products & Services of Ceva
20.Table Products & Services of Elanco/Eli Lilly
21.Table Products & Services of Sindh Poultry Vaccine Centre
22.Table Products & Services of Bio-Labs
23.Table Products & Services of Vaksindo
24.Table Market Distribution of Major Players
25.Table Global Major Players Sales Revenue (Million USD) 2017-2020e
26.Table Global Major Players Sales Revenue (Million USD) Share 2017-2020e
27.Table Global Veterinary Vaccine Market Forecast (Million USD) by Region 2021f-2026f
28.Table Global Veterinary Vaccine Market Forecast (Million USD) Share by Region 2021f-2026f
29.Table Global Veterinary Vaccine Market Forecast (Million USD) by Demand 2021f-2026f
30.Table Global Veterinary Vaccine Market Forecast (Million USD) Share by Demand 2021f-2026f